Broadcom Recovers Ground, but the Analyst Gap Remains the Story

AVGO has moved from a tentative floor to a genuine weekly gain, closing at $342.33 after rising 4% on Tuesday alone, yet the stock still trades at a 55% discount to the Street's mean price target of $530.

The recovery is real and broad-based. The stock is up 2.4% on the week and 4% on the day, clawing back meaningful ground from the $321.68 low reported in the last note. Peers confirm the sector is moving with it: CEVA gained 8.6% on the week, AOSL added 6.4%, and ARM rose 2.5%. The prior two notes documented a brutal multi-week selloff and only the most tentative stabilisation. The data now shows the stabilisation has become something more decisive, though the weekly gain of 2.4% barely dents the month's 3% decline. Two prior earnings prints moved the stock down 2.5% and 3.4% the next day respectively. The next event is December 10, giving the market six weeks to close or widen the gap before results force a verdict.

Options positioning is slightly more cautious than usual, but not at an alarm level. The put/call ratio is running at 1.04, just above its 20-day average of 1.01, with a z-score of 1.2. That is modestly elevated but well short of the year's high of 1.23, suggesting investors are buying a little more downside protection than average without expressing strong conviction about a selloff. The borrow market tells the same low-pressure story: with shares freely available, short interest is a structural non-issue at just 1.2% of free float. Short sellers trimmed 1.6% of their position on the week even as the one-month figure shows a 13% build, a mix that says bears added into weakness and are now pulling back into strength. Cost to borrow is 0.22%, trivial for a $1.6 trillion company.

The Street's conviction is the standout feature of this note. Forty-one analysts rate AVGO a buy against just two holds. The most recent action, Tigress Financial initiating with a $600 target on October 22, sets the high end of a range that runs from DA Davidson's $350 (the sole bear-adjacent voice, maintained at Neutral after cutting from $400 in September) to Evercore ISI's $578. Citigroup raised its target to $515 from $500 after the September results. The bull case rests on AI semiconductor revenue up 221% year over year to $16.7 billion, custom XPU shipments more than tripling, and VMware's software stream contributing $8.75 billion at approximately 94% gross margins. The bear case is more nuanced: near-term revenue guidance missed the market's high bar, gross margin is expected to drift toward 72% as AI silicon mixes up, and the valuation leaves limited room for a macro or capex shock. The current PE of 18.9x and EV/EBITDA of 15.4x are not stretched by historical standards, but the analyst rec score ranks in the 91st percentile of the market, meaning consensus is unusually bullish relative to peers.

Retail attention is running notably hot. Wikipedia views for Broadcom carry a z-score of 2.0 against the prior 90 days, placing attention well above its own recent baseline. That is a measure of awareness, not a revenue signal, but it is consistent with the Meta Platforms disclosure covered in the previous note: the story of Broadcom as potential Meta shareholder and custom-silicon supplier simultaneously has drawn unusual public interest. Buyback data from EDGAR shows spend in Q2 of fiscal 2026 was $600 million, down 76% on the same quarter a year earlier, with shares repurchased down 88%. The company deployed cash elsewhere; free cash flow for fiscal Q3 2026 was reported at $13.67 billion.

What to watch between now and December 10 is whether the recovery above $342 can hold against a backdrop of sector volatility, and whether any revision to hyperscaler capex guidance from Meta, Google, or Microsoft shifts the analyst community's confidence in the $115 billion AI semiconductor revenue target management has set for fiscal 2027.